Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Standard Biotools (LAB) over the last 14 years, with Q3 2025 value amounting to $54.0 million.

  • Standard Biotools' Change in Acquisitions & Divestments rose 800.0% to $54.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.0 million, marking a year-over-year decrease of 3206.35%. This contributed to the annual value of $349.0 million for FY2024, which is 19585.3% up from last year.
  • According to the latest figures from Q3 2025, Standard Biotools' Change in Acquisitions & Divestments is $54.0 million, which was up 800.0% from $48.0 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Change in Acquisitions & Divestments ranged from a high of $127.0 million in Q2 2024 and a low of $12.0 million during Q3 2022
  • Moreover, its 4-year median value for Change in Acquisitions & Divestments was $50.5 million (2023), whereas its average is $56.2 million.
  • Per our database at Business Quant, Standard Biotools' Change in Acquisitions & Divestments soared by 21002.83% in 2024 and then tumbled by 6220.47% in 2025.
  • Over the past 4 years, Standard Biotools' Change in Acquisitions & Divestments (Quarter) stood at $41.0 million in 2022, then crashed by 36.59% to $26.0 million in 2023, then skyrocketed by 130.77% to $60.0 million in 2024, then dropped by 10.0% to $54.0 million in 2025.
  • Its last three reported values are $54.0 million in Q3 2025, $48.0 million for Q2 2025, and $52.0 million during Q1 2025.